You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
億勝生物科技(01061.HK)前五月溢利同比大幅減少約70%
格隆匯 06-22 18:14

格隆匯 6 月 22日丨億勝生物科技(01061.HK)公佈,集團於截至2020年5月31日止五個月的溢利較2019年同期大幅減少約70%。

該減少主要歸因於在中國多個省市採取的政府限制措施以遏制新型冠狀病毒(COVID-19)擴散,這對中國醫院的門診運作造成重大影響,並阻礙非緊急病人前往醫院及門診診所。

於公佈日期,儘管醫院及門診診所的門診運作與該期間相比於2020年6月明顯改善,但尚未完全恢復到COVID-19疫情爆發之前的正常水平。

儘管本集團在中國及海外的臨牀試驗計劃經歷兩到三個月期間的推遲,但集團的基礎研發項目及營運於該期間受到的干擾不大。

縱然存在上述情況,集團仍維持穩健之現金流量及財務狀況以滿足其業務需求。集團2020年中期期間的業績及表現可能出現變動,視乎COVID-19疫情的發展情況及有關集團若干資產公平值變動之影響而定。 

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account